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Abstract
Background: Many Nigerian children with malaria are treated at home. Treatments are mostly
incorrect, due to caregivers' poor knowledge of appropriate and correct dose of drugs. A
comparative study was carried out in two rural health districts in southwest Nigeria to determine
the effectiveness of a guideline targeted at caregivers, in the treatment of febrile children using
chloroquine.
Methods: Baseline and post intervention knowledge, attitude and practice household surveys
were conducted. The intervention strategy consisted of training a core group of mothers ("mother
trainers") in selected communities on the correct treatment of malaria and distributing a newly
developed treatment guideline to each household. "Mother trainers" disseminated the educational
messages about malaria and the use of the guideline to their communities.
Results: Knowledge of cause, prevention and treatment of malaria increased with the one-year
intervention. Many, (70.4%) of the respondents stated that they used the guideline each time a child
was treated for malaria. There was a significant increase in the correct use of chloroquine from
2.6% at baseline to 52.3% after intervention among those who treated children at home in the
intervention arm compared with 4.2% to 12.7% in the control arm. The correctness of use was
significantly associated with use of the guideline. The timeliness of commencing treatment was
significantly earlier in those who treated febrile children at home using chloroquine than those who
took their children to the chemist or health facility (p < 0.005). Mothers considered the guideline
to be explicit and useful. Mother trainers were also considered to be effective and acceptable.
Conclusion: The use of the guideline with adequate training significantly improved correctness of
malaria treatment with chloroquine at home. Adoption of this mode of intervention is
recommended to improve compliance with drug use at home. The applicability for deploying
artemisinin-based combination therapy at the community level needs to be investigated.
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Background
In Nigeria, the main strategy for reducing childhood mor-
bidity and mortality is presumptive treatment of all fevers
in children under five with antimalarial drugs [1]. This is
in line with World Health Organisation (WHO) recom-
mendation for endemic countries where the availability
and use of laboratories are limited [2].
Malaria control activities in Nigeria are planned and
implemented through the Primary Health Care (PHC)
system [1]. However, use of health centres, as the first
resort for malaria management has been shown to be low
in many African studies including Nigeria. It is estimated
that only about 20% of malaria episodes are treated in the
health centres [3]. A review of mothers' malaria treatment-
seeking behaviour in rural south-western Nigeria revealed
that more than 80% of malaria episodes received treat-
ment outside of the existing government healthcare sys-
tem [4,5]. Reasons underlying this practice include
difficulty with access to health centre, scarcity of afforda-
ble drugs including antimalarial drugs, perceived deficien-
cies in the performance of formal health services
including poor clinical skills, attitude of health personnel
and cultural beliefs [6,7]. These shortcomings encourage
treatment of malaria at home with drugs bought from
shops and herbal preparations [8,9]. These treatments are
usually incorrect or sub-optimal [10-12]. Mothers and car-
egivers only usually visit a health centre or hospital after
the illness has failed to respond to several drugs and inef-
fective self treatment. This practice increases morbidity
and mortality in addition to contributing to possible
emergence of drug resistance [6,13].
Prompt and effective treatment of malaria remains a chal-
lenge for malaria control programmes. From the moment
a patient experiences the first symptom of malaria to the
point when the disease has been cured; many potential
barriers have to be overcome. These include delays in rec-
ognition of symptoms and treatment seeking, and non-
adherence to the drug regimen. Helping caregivers to
overcome these and other barriers to prompt and effective
treatment of malaria is of particular importance in sub-
Saharan Africa.
Despite the considerable success recorded from past inter-
ventions to improve compliance to correct doses of chlo-
roquine (CQ) in uncomplicated malaria [9,13-17], the
practice of inappropriate and incorrect home manage-
ment of malaria still persists in many communities espe-
cially in the rural areas. Another observation is that most
of the interventions were pre-determined by the investiga-
tors with little or no input from the members of the com-
munities. Furthermore, investigators often supplied the
antimalarial drugs used (usually chloroquine), with no
adequate mechanism put in place to ensure that the same
quality of drugs used for the studies continued to be avail-
able in the community.
Efforts during this study was devoted to determining the
baseline knowledge and practice of mothers/caregivers in
the management of malaria in children, to providing
training on correct dosage and regimen of the drug of
choice for treating malaria (chloroquine) at the time of
the study and evaluating the effectiveness of a newly
designed treatment guideline.
Methods
Study design
A comparative study was carried out in two rural health
districts ; one health district belonged to the intervention
arm while the other was the control arm. Outcome meas-
ures were evaluated in both arms before and after inter-
vention. The study was conducted in three phases. The
first phase involved advocacy, community mobilization,
baseline survey and selection of "mother trainers". Infor-
mation, Education and Communication (IEC) materials
were developed and research staff recruited and trained.
The intervention phase involved the development of a
treatment guideline, training of "mother trainers" and dis-
tribution of the guideline. A year after commencement of
guideline distribution, a household survey, interviewing
eligible caregivers about management of childhood fevers
in the preceding two weeks, was performed to evaluate the
intervention.
A longitudinal follow-up study was nested into this study
in order to collect data on treatment outcome (reported in
a separate manuscript). The nested study entailed daily
visits of study team to identify children with febrile ill-
ness, ask questions about treatment practices and collect
finger pricked blood sample for microscopy on Days
0,1,2,3,7 and 14. These visits were carried out for nine
months. The main study continued for another three
months prior to post intervention survey.
Ethics
The Joint University of Ibadan/University College Hospi-
tal Ethical Committee provided ethical approval for the
study. Permission to carry out the study in the selected vil-
lages was obtained from the village heads and community
opinion leaders. Heads of households or their representa-
tives gave permission for household survey. Individual
verbal informed consent was also obtained from each car-
egiver interviewed.
Study location
This study was conducted in two rural districts selected by
random sampling from the eight health districts that
make up Ona-Ara Local Government area (LGA), in south
western Nigeria from March 2002 to October 2004. TheMalaria Journal 2008, 7:24 http://www.malariajournal.com/content/7/1/24
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two health districts were allocated into intervention or
control arm by balloting. Ona-Ara LGA is one of 33 LGAs
in Oyo State. It is located about 35 km east of Ibadan, the
capital of the state and has 26,976 households with a pop-
ulation of about 147,847 people, out of which 33,126 are
children and 33,576 are women of childbearing age (Pro-
jected figure, 1997). Ona-Ara LGA comprises 200 villages
that are divided into 8 health districts [18], six of which
are rural and two, are urban/peri-urban. Each of the two
health districts has a health/maternity centre and a pri-
mary health centre is located at Akanran the headquarters
of the LGA.
The inhabitants are mainly peasant farmers and traders
from the Yoruba ethnic group. The climate is that of trop-
ical rainforest zone, with a warm dry-season from Novem-
ber to April and a rainy season from May to October.
Malaria is hyper-endemic in the LGA with perennial trans-
mission. Home-treatment of malaria using drugs pur-
chased from private outlets is common.
Study population
Mothers or female caregivers who have resided in the
community for at least one year, have at least a child ≤ 10
years and consented to participate in the study were
enrolled. Mothers or female caregivers who provided care
to children only on short term basis such as day care set-
tings and children with severe illness were excluded.
Sample size
The sample size for the survey was calculated using com-
pliance rate of 25% for chloroquine when used at home
to treat febrile illness presumed to be malaria [19]. To
have a 90% power of detecting a significant effect if the
intervention increases the proportion of correct use of CQ
by 50%, assuming a design effect of two, the minimum
number of children required in each group was 280. These
were selected from the study districts using probability
proportional to size sampling technique.
Intervention
Mothers numbering two to 10 per village depending on
size of the village (one per 50 households) were selected
by the community to be trained as "mother trainers".
Selected "mother trainers" were trained to form a core
group of mothers to provide education on malaria diag-
nosis, treatment and prevention to other caregivers/moth-
ers in their communities. During the training, "mother
trainers" understanding of the local terminology 'Iba' and
the researchers' terminology for malaria was clarified. It
was made clear that malaria in the Yoruba language is
consistent with "iba" and is recognized by symptoms asso-
ciated with malaria such as fever, vomiting, chills, ano-
rexia, weakness, yellow urine and headache as reported by
Falade et al. [17].
A treatment guideline was developed using participatory
approach involving "mother trainers" and community
members. Pictorial illustrations of some common clinical
features of uncomplicated and complicated malaria, the
steps to take for the different types of presentation of
malaria and the correct dose and regimen of chloroquine
treatment according to the age of the child were used and
presented as cartoons (Figures 1, 2 &3). Chloroquine was
the first drug of choice for malaria treatment in Nigeria at
the time of this study. The Federal Ministry of Health,
Nigeria adopted artemisinin-based combination therapy
(ACT) as first line drug for uncomplicated malaria in line
with the WHO recommendation in January 2005 [1].
The developed treatment guideline was distributed by
mother trainers to every household in their communities
and some were pasted on the walls of prominent build-
ings in the communities. Information on how to use the
guideline was also provided. Drug sellers in the interven-
tion arm of the study were also trained about the correct
management of malaria using CQ and the guideline was
distributed to them too.
No form of intervention was carried out in the communi-
ties in the control arm of the study. Mothers were left to
continue their usual treatment practices for malaria. They
were not provided with the treatment guideline. With the
collaboration of the Primary Health Care unit of the LGA,
the site was monitored to ensure that no form of project
related to malaria or that, which may confound findings
in this study was carried out. It was planned that if the
intervention was found effective, it will be introduced into
the communities in the control arm of the study.
Evaluation
Twelve months after commencement of distribution of
the guideline, a two week fever recall household survey
among study population was carried out to evaluate the
intervention. The primary outcome which was correctness
of use of chloroquine was measured using caregivers'
recall of dose of chloroquine given to febrile children as
well interval and duration for which it was given.
Data collection methods
An investigator administered questionnaire was used to
collect data for the household survey. The household sur-
vey focused on the caregivers' knowledge about malaria
and their health seeking behaviour for fever in children
presumed to be malaria.
The questionnaire used was adapted from a related past
study conducted in Togo [20] and complementary ques-
tions were added using findings from pilot focus group
discussions. The questionnaire was translated from
French to English and back translated to French by inde-Malaria Journal 2008, 7:24 http://www.malariajournal.com/content/7/1/24
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pendent translator to ensure correct translation [see Addi-
tional file 1], The questionnaire was then translated into
"Yoruba" (local language in the study area) and back
translated to English by an independent translator. The
questionnaire was face validated and tested for reliability
using test-retest reliability method. The reliability co-effi-
cient was 0.85 at 5% level of significance.
Drug supply
Mothers were requested to buy chloroquine from their
usual drug sources. Most mothers in this study area usu-
ally purchase chloroquine from drug hawkers and patent
medicine sellers (PMS).
Data analysis
Data entry and statistical analysis were conducted using
EPI info version 6.02. Chi Square test for categorical vari-
ables, t-test for continuous variables, and non-parametric
test (Kruskal-Wallis test) were used to investigate associa-
tions, compare proportions and compare means respec-
tively at 5% level of significance.
Results
Six hundred and eleven (281 in control and 330 in the
intervention group) mothers/caregivers were studied at
baseline. The mean ages (SD) of the mothers were 37.1
(13.3) and 37.5 (13.9) years respectively, (p = 0.73). Six
hundred and four mothers (304 in control and 300 in the
intervention groups), with mean (SD) ages 34.5 (13.3)
and 36.6 (3.4) years respectively, p = 0.09 were inter-
viewed during post-intervention survey.
Impact of intervention on mothers' knowledge of 
symptoms and signs, cause, prevention and treatment of 
malaria
At baseline, 13 of the 330 (3.9%) mothers knew the cor-
rect cause of malaria while 228 of 300 (76.0%) men-
tioned mosquito bites after the intervention (Table 1).
How to treat uncomplicated malaria at home Figure 1
How to treat uncomplicated malaria at home. -Scenario showing the presentation and treatment of uncomplicated 
malaria in the home.Malaria Journal 2008, 7:24 http://www.malariajournal.com/content/7/1/24
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Chemoprophylaxis was the most common method of pre-
vention of "Iba"  mentioned by 143/171 (80.9 %) and
185/255 (72.5%) pre- and post- intervention respectively.
Further details are shown in Table 1. The drug mostly
mentioned as being the most important in treating
malaria were antimalarial drugs comprising chloroquine
and sulphadoxine-pyrimethamine commonly Fansidar®
mentioned by 162/324 (50.0%) and 217/296 (73.3%)
pre and post intervention respectively, (χ2 = 68.91, df = 5,
p = 0.000). Further details are shown in Table 1. None of
the respondents mentioned artemisinin-based antimalar-
ial drug. There was no significant difference in responses
to these variables pre and post intervention in the control
group (p > 0.05).
Effect of intervention on the care seeking practices of 
mothers for febrile illness presumed to be malaria
A total of 513 children (247; intervention and 266; con-
trol group) had an episode of fever in the three months
preceding post intervention survey. In some households
more than one child under 10 years had fever during this
period. Further documentation on the management of
febrile illness was carried out for 459 (89.5%) children
(229; intervention and 230; control group) who had fever
two weeks preceding the survey. The frequency distribu-
tion of the presumed diagnosis of febrile illness is shown
in Table 2. A significant change was demonstrated after
intervention (χ2 = 17.5, df = 5, p = 0.004), with more
mothers in the intervention arm presuming febrile illness
to be malaria ("iba") than those in the control arm. How-
ever, the proportion of mothers who presumed "iba" as
diagnosis in the intervention arm was the same at pre- and
post- interventions. The types of first treatment given to a
febrile child in the two arms are shown in Table 3. Treat-
ment at home with orthodox drug was the most men-
tioned in both arms. Details of observed changes in both
study arms pre and post intervention are shown in Table
3.
Uncomplicated malaria that did not respond to home treatment Figure 2
Uncomplicated malaria that did not respond to home treatment. -Scenario showing the presentation and manage-
ment of uncomplicated malaria that did not respond to home treatment.Malaria Journal 2008, 7:24 http://www.malariajournal.com/content/7/1/24
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The types of drugs bought by mothers who gave drugs at
home are shown in Table 4. Post – intervention, the most
common drug bought for treating malaria in the interven-
tion arm changed from paracetamol (PCM)/PCM deriva-
tives to chloroquine (p = 0.003) while it still remained as
PCM/PCM derivatives in the control arm (p = 0.17).
Severe malaria should be taken to the hospital Figure 3
Severe malaria should be taken to the hospital. -Scenario showing the presentation and management of severe malaria.
Table 2: Frequency distribution of presumed diagnosis of febrile illness in the child
Diagnosis BaselineIntervention Post intervention
Intervention 
N = 322 n (%)
Control 
N = 257 n (%)
Intervention 
N = 229 n (%)
Control
 N = 230 n (%)
"Iba" (Malaria) 267(82.9) 222(86.4) 189(82.5) 173(75.2)
"Iba Ponju" (Yellow fever) 1(0.3) 1(0.3) 6(2.6) 21(9.1)
"Iko ile tutu" (Pneumonia) 4(1.2) 0(0.0) 10(4.4) 16(7.0)
"Ogbele" (Measles) 6(1.9) 2 (0.8) 2(0.9) 6(2.6)
"Cough" 2(0.6) 3(1.2) - -
Don't know 20(6.2) 20(7.8) - -
Others 22(6.8) 9(3.5) 22(9.6) 14 (6.1))
X2 = 5.07; p = 0.28 X2 = 17.5; p = 0.004Malaria Journal 2008, 7:24 http://www.malariajournal.com/content/7/1/24
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In the intervention arm, one hundred and sixty-seven of
202 (82.7%) caregivers who treated febrile children at
home bought drugs from hawkers at baseline. This was
followed by PMS/chemist mentioned by 30 (14.4%) and
Table 1: Table showing improvement in mothers' knowledge on cause of malaria, prevention and drug most important in the 
treatment of malaria.
Intervention arm only
Baseline
(n = 330)
Post intervention
(n = 300)
Level of significance
*Perceived cause of malaria
Playing in the sun 144 (43.6%) 87 (29.0) X2 = 13.87; p = 0.0002
Playing in the rain 48 (14.5%) 32 (10.7%) X2 = 1.80; p = 0.18
Drinking dirty water 21 (6.4%) 18 (6.0%) X2 = 0.0; p = 0.98
Mosquito bite 13 (3.9%) 228 (76.0%) X2 = 342.4; p < 0.0001
Inherited 15 (4.5%) 9 (3.0%) X2 = 0.65; p = 0.42
Too much work 9 (2.7%) 7 (2.3%) X2 = 0.0; p = 0.95
Dirty surroundings 24 (7.3%) 18 (6.0%) X2 = 0.23; p = 0.63
Eating too much palm oil 8 (2.4%) 3 (1.0%) X2 = 1.12; p = 0.29
Knowledge of prevention
Total number that said malaria can be prevented 177 (53.6%) 255(85%) X2 = 41.62; p < 0.0001
*Prevention methods known
Chemoprophylaxis 143 (80.8%) 185 (72.5%) X2 = 0.25; p = 0.62
Prevent water puddles 8 (4.5%) 35 (13.7) X2 = 8.88; p = 0.002
Bednets 5 (3.0%) 31 (12.2%) X2 = 10.72; p = 0.001
Insecticides 10 (5.6%) 3 (1.2%) X2 = 5.71; p = 0.02
Barrier cream 5 (3.0%) 3 (1.2%) X2 = 0.79; p = 0.28
Avoid sun, rain and dust 3 (1.7%) 2 (0.7%) X2 = 0.0; p = 1.0
Drug most important for treatment of malaria N = 324 N = 296
Antimalarial drugs (CQ, Fansidar®) 162 (50.0) 217 (73.3%) X2 = 68.91; p < 0.0001
Paracetamol 117 (36.1) 73 (24.7%)
Haematinics/vitamins 16 (4.9) 4 (1.4%)
NSAIDs 1 (0.3) 0 (0.0%)
Antibiotics 5 (1.5) 2 (0.7%)
Don't know 23 (7.1) 0(0.0%)
* Multiple responses
Table 3: The distribution of first treatment given to the child at home during last episode of febrile illness.
Baseline Post intervention
First treatment Intervention
 n (%)
Control
 n (%)
Intervention
 n (%)
Control
 n (%)
Gave drugs bought from chemist at home 233 (71.5) 185 (73.1) 183 (79.9) 141 (61.3)
Gave traditional herbs at home 37 (11.3) 29 (11.5) 10 (4.4) 32 (13.9)
Took child to health facility 37 (11.3) 23 (9.1) 21(9.2) 41(17.8)
Took child to chemist/PMS 18 (5.5) 13 (5.1) 15 (6.6) 16 (7.0)
Took child to traditional healer 1 (0.3) 3 (1.2) 0 (0.0) 0 (0.0)
Total 326 (100) 253 (100) 229(100) 230(100)
X2 = 2.39; p = 0.67 X2 = 23.45; p < 0.0001Malaria Journal 2008, 7:24 http://www.malariajournal.com/content/7/1/24
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health centre by 5(2.5%) caregivers (χ2 = 32.11, df = 2, p
= 0.0001). After intervention, 104/179 (58.1%) mothers
in the intervention arm mentioned they bought drugs
from PMS/chemist, 70 (39.1%) from drug hawkers and 5
(2.8%) from health centres/dispensary. There was no sig-
nificant difference in the source of drug post intervention
in the control arm (p = 0.59).
Awareness and use of guideline
The findings on the awareness and perceived usefulness of
the guideline by mothers irrespective of the treatment
option used are summarized in Table 5. None of those in
the control group mentioned they used a guideline. In the
intervention group, 125 out of 183 (68.3%) of those who
treated their children at home using orthodox drugs irre-
spective of drug used mentioned that they used the guide-
line in treating the sick children. Three out of 15 (20.0%)
and 6/21 (28.6%) mothers who took their children to a
chemist or health facility respectively mentioned that they
used the guideline.
Correctness of use of chloroquine
At baseline, 3/116 (2.6%) (intervention) and 3/72 (4.2%)
(control) caregivers who used chloroquine at home used
Table 4: Frequency distribution of drugs bought from the chemist/itinerant drug sellers
Name of drug Intervention Control
Baseline
N = 189
n (%)
Post
N = 178
n (%)
Baseline
N = 141
n (%)
Post
N = 134
n (%)
Paracetamol *140(74.1) 106 (59.5) *103 (73.0) *104 (77.6)
Vitamins/blood tonic 109 (57.7) 128 (71.9) 65 (46.1) 84 (62.7)
Chloroquine 85 (45.0) *130 (73.0) 43 (30.5) 49 (36.6)
Antibiotics 21 (11.1) 18 (10.1) 10 (7.1) 17 (12.7)
"Akapo"1 18 (9.5) 9 (5.1) 18 (12.8) 12 (8.9)
Chlorpheniramine 6 (3.2) 10 (5.6) 6 (4.3) 2 (1.5)
Aspirin 5 (2.6) 3 (1.7 6 (4.3) 4 (3.0)
X2 = 19.88; p = 0.003 X2 = 9.15; p = 0.17
Note: There were multiple responses. * = The most mentioned in each group
Table 5: Summary of mothers' responses to variables on awareness and usefulness of the guideline. (Intervention group)
Variables Responses Frequency (%)
Did you see the guideline distributed to mothers on treatment of 
malaria? (N = 300)
Saw the guideline 264 (88.0%)
Do you have the treatment guideline in your household? (N = 300) Had the calendar type in their household 204 (68.0%)
Did you use the guideline? (N = 204) Used guideline each time a child had "iba" 145(71.1%)
Did not use guideline all the time child had "iba" 59 (28.9)
Why did you not use the guideline? (N = 59)
- Did not treat child with chloroquine 14 (23.7%)
- had training on treatment before 10 (16.9%)
- Child reacts to chloroquine 10 (16.9%)
- Forgot to use guideline 7 (12.0%)
- No response 18 (30.5%)
Was the guideline useful? (N = 204)
Very useful 168 (82.4%)
Useful 23 (11.3%)
Undecided 11 (5.4%)
Not useful 2 (0.9%)
What benefits did you derive from using the guideline? (N = 204)
Provided knowledge on correct dose of chloroquine 188 (92.2%)
Taught mothers to keep environment clean 8 (3.9%)
- Guideline was free 8 (3.9%)
What difficulties did you experience in using the guideline? (N = 14)
Could not comprehend it 11 (78.6%)
Kept forgetting the instructions 3 (21.4%)Malaria Journal 2008, 7:24 http://www.malariajournal.com/content/7/1/24
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it correctly. None of those who took their children to
chemist or health facility in the control and intervention
arm and was prescribed CQ used it correctly.
After intervention, chloroquine was used correctly in
terms of dose and duration among caregivers who treated
children at home with drugs in 69/132 (52.3%) and 9/57
(15.8%) cases in intervention and control arm respec-
tively, χ2 = 20.38; p < 0.001. When compared with base-
line findings [3/116 (2.6%) versus 69/132(52.3%)] there
was a significant positive change in the correct use of chlo-
roquine in the intervention group [OR = 0.02, 95% CI
0.00–0.008], (p < 0.001) while there was no significant
change in the control group [3/72 (4.1%) versus 9/
57(15.8%)], (p = 0.05).
Post intervention, 3/15 (20.0%) respondents in the inter-
vention group who took their children to a chemist/PMS
and used CQ, used it correctly while none of the mothers
in the same category in the control group used it correctly.
Two out of 26 (7.7%) who took their sick children to
health facility used it correctly. This comprised of one
each in intervention [1/9 (11.1%)] and control group [1/
17 (5.9%)].
Use of the guideline was significantly associated with cor-
rectness of use of CQ, (p < 0.001) [OR = 44.63, 95% CI
7.63–433.4]. In the intervention arm, 42 out of 50
respondents (84.0%) who used chloroquine following
the guideline administered chloroquine correctly, com-
pared to two out of 19 (10.9%) who did not use the guide-
line (p < 0.001). Also, use of the guidelines was
significantly associated with the level of education (χ2 =
4.91, p = 0.03). Caregivers who had at least primary edu-
cation constituted the largest percentage of those who
used the guidelines [85/145;58.6%] while those who did
not have any education were the most among those who
did not use the guidelines [45/59;76.3%]. There was no
significant association between use of the guidelines and
other demographic characteristics
Timeliness of treatment
All the 230 caregivers in the intervention group and 182
in the control group who treated with orthodox drugs at
home at baseline commenced treatment within 24 hours
of mother noticing fever while 176/178 (98.9%) and 138/
139 (99.3%) respectively did so post intervention. The
proportion of mothers who took sick children to the
chemist within 24 hours of noticing fever increased from
17/18 (94.4%) at baseline to 15/15 (100%) post interven-
tion in the intervention arm (p = 0.93) while 6/7 (85.7%)
and 10/12 (83%) did so at baseline and post intervention
respectively in the control arm (p = 0.61). There was a
reduction in the proportion of mothers who took febrile
children to a health facility within 24 hours of noticing
fever from 20/26 (76.9%) to 15/21 (71.4%) in the inter-
vention arm (p = 0.67) and 17 (100%) to 30/41 (73.2%)
in the control arm (p = 0.02).
Microscopic diagnosis and treatment outcome
Thick blood smears results were available on D0 for 162
febrile children [88, control arm and 74 intervention]; 64/
88 (72.7%) and 62/74 (83.7%) had patent parasitaemia
in the control and intervention arms respectively. Parasite
density ranged from 40/µl to 120,000/µl with only nine
children with a parasite density < 800 parasites/µl. The
sensitivity and specificity of caregivers' diagnosis were
78.1% and 29.2% versus 82.3% and 8.3% in the interven-
tion and control arms respectively. Complete blood smear
reports were available for 49 and 46 children in the con-
trol and intervention arm respectively. Day 14 cure rates
were 63.3% (31/49) and 91.3% (42/46) in the control
and intervention arms (p < 0.001).
Referrals to the health facilities during the one year 
intervention period
Six of 183 febrile children treated at home in the interven-
tion arm and 15/141 (10.6%) in the control arm were
taken by mothers/caregivers to health care facility (HCF)/
chemist, (p = 0.009). Children were taken to HCF/chemist
because of failure to improve mentioned by 17 (81.0%)
respondents and need to be sure the child is cured", by
four (19.0%). Twelve (51.1%) of these children were
taken to HCF/chemist within 24 hours of onset of fever
(4/6; intervention and 8/15; control arm) and nine
(42.9%) others thereafter.
There was marked reduction in number of cases of malaria
attended to during the intervention period compared to
baseline based on the entry in the attendance registers in
the health centres. However, record keeping by the health
facilities was found to be grossly inadequate in this LGA.
Discussion
The results of this study showed that provision of health
education on malaria can improve caregiver's knowledge
of malaria. The level of knowledge of causation, symp-
toms, and signs of malaria, treatment and prevention
determines the extent to which appropriate steps are taken
to prevent occurrence and treat a case adequately. During
this study, knowledge of causation and prevention of
malaria by caregivers were found to be poor at baseline.
These findings are similar to those of past studies con-
ducted in rural areas in Nigeria and other endemic coun-
tries where level of education of mothers was generally
low [17,21,22]. This is in contrast to studies carried out in
literate communities where as high as 82% of caregivers
correctly related mosquito bite to malaria [23-26].Malaria Journal 2008, 7:24 http://www.malariajournal.com/content/7/1/24
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There was no concordance between method of prevention
and perceived causes of malaria mentioned by the moth-
ers. The expectation is that their prevention practices will
be targeted towards perceived causes. This corroborates
previous reports that peoples' thought about preventing
malaria and preventing mosquito bites were not congru-
ent [21,25]. The improvement in knowledge in the inter-
vention arm of this study demonstrated the positive
impact of health education on caregivers' knowledge and
provided further evidence for the use of trained lay people
to deliver educational messages to community members
[9,14,16].
A high proportion of mothers in both arms of the study
made presumptive diagnosis of malaria in their febrile
children. This was more frequent in the intervention arm
post intervention. When presumptive diagnosis and
results of microscopy obtained during the follow-up study
nested into this study were compared, the sensitivity and
specificity of caregivers' diagnosis were 78.1% and 29.2%
versus 82.3% and 8.3% in the intervention and control
arms respectively (reported in another manuscript sub-
mitted for publication). This is encouraging because as
many as eight out of ten cases of malaria were correctly
diagnosed by mothers and if prompt and correct treat-
ment is given the morbidity and mortality of children
from malaria will be reduced drastically. This is in support
of the WHO policy that all febrile illness in children < 5
years of age in malaria endemic areas be treated as malaria
[2]. On the other hand however, the high frequency of
presumptive diagnosis of malaria in febrile children could
be dangerous for those children who did not have malaria
as this would lead to delay in seeking appropriate treat-
ment.
The finding in this study also demonstrated that it is pos-
sible to remarkably improve mothers'/caregivers' adher-
ence to chloroquine treatment for children through
provision of health education by trained lay people in the
community and distribution of treatment guideline. The
approach taken in this study was similar to that used for
studies carried out to improve home treatment practices
of caregivers in some other endemic countries in sub-
Saharan Africa [13-17]. The improvement in level of
adherence from 2.6% to 53.5% in the intervention arm of
this study is well over the target of 50% increase and com-
pared well with those reported in some past studies
[9,13,14,17]-. In a controlled health facility based study
by Okonkwo et al., (2001) adherence in the intervention
group was 73.3% compared to 36.5 in the control group.
Salako et al., (2001) reported compliance increased from
14.3% to 26.7%. In the study by Adeniyi et al., improved
compliance from 27.8% to 98.1% was reported while Pag-
noni et al reported an increase in compliance by number
of doses of CQ administered from 0.8% to 12.9% and in
terms of correct duration of treatment from 5.6% to
18.9%. In all the above studies compliance was measured
by recall. In addition, Okonkwo et al., did volumetric
measurement of the left over chloroquine syrup.
This study unlike those mentioned, provided a treatment
guideline which included story presented as cartoon to
help with early diagnosis and referral as well as dosing
schedule for chloroquine use in uncomplicated malaria to
all households. Also, special drug or pre-pack drugs were
not provided to mothers; they were requested to buy anti-
malarial drugs from their usual drug source. Compliance
was measured by recall as was the case in the earlier stud-
ies.
In this study, daily monitoring of patients for the nested
follow-up study was carried out for nine months. Research
assistants were withdrawn from the communities for three
months prior to conduct of the post intervention survey.
The frequent presence of research assistants in the study
communities could have influenced the use of the guide-
line by caregivers and subsequently the correct use of
chloroquine. The increase in proportion of those who
used CQ correctly in the control arm could also be attrib-
uted to the frequent visit of research assistants. This is
more so that no form of intervention or malaria control
programme was carried out in the control health district.
However, it was presumed that the three months absence
of assistants from the field would be enough to reduce the
influence of the team's presence on compliance. Other
factors that may be responsible are the repeated health
education provided by "mother trainers" to the interven-
tion communities and the availability of the treatment
guideline to every household to which mothers could
refer.
The significant association of the use of the treatment
guideline with correct use of chloroquine confirms the
effectiveness of the guideline to improve compliance. This
was also associated significantly with improved cure rate.
This demonstrates that mothers could be trained to use
chloroquine correctly at home by providing a simple
guide. The fact that the use of the guideline was signifi-
cantly associated with the level of education suggests that
having some form of education provided a probable
advantage in understanding of the guideline. However,
this was not reflected in the correctness of the use of chlo-
roquine as this was not significantly associated with the
level of education of respondents. While it is possible that
the positive impact of training a core group of mothers
and producing guidelines on malaria treatment is main-
tained with the switch of first line drug to ACT, this may
not be straight forward as the dose regimen for some ACTs
is different from that of CQ. Hence, the applicability ofMalaria Journal 2008, 7:24 http://www.malariajournal.com/content/7/1/24
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the intervention to ACT use at community level needs to
be tested.
Despite the fact that this study unlike others did not pro-
vide CQ to mothers/caregivers, the use of CQ increased in
the intervention arm after intervention. This could be that
more mothers opted to buy CQ subsequent to improved
knowledge of treatment of malaria and the confidence in
their ability to use CQ correctly [14]. The drug vendors
who were also provided training and the treatment guide-
line could have increased the sale of antimalarial drug
subsequent to the training they also had [15] and possibly
increase demand by the caregivers.
The proportion of correct use of chloroquine was highest
among those who treated malaria at home with drugs
bought from drug sellers. It is also of note that most of
them started treatment within 24 hours of noticing fever
in the children. Mothers/caregivers who took ill children
to chemist or health facility started later than 24 hours.
This corroborates findings in past studies in southwest
and southeast Nigeria [5,13] and confirms the feasibility
of treating malaria promptly and correctly at home with
adequate provision of effective health education and pro-
vision of guideline to mothers.
The relatively poor compliance by those who consulted at
health facility and chemist could be a reflection of the
inadequate knowledge of the attendants and conse-
quently poor provision of information on drug use to
mothers. This underscores the need to train drug distribu-
tors on the correct use of chloroquine and also to encour-
age positive change in their attitudes. Marsh et al. in an
earlier study had reported that shopkeepers constitute an
effective channel for intervention to the community. In
the study by Marsh et al., plasma drug levels of children
treated by shop keepers were assayed to determine the
appropriateness and correctness of chloroquine sold and
dispensed over-the-counter after training. The design of
this study allowed mothers to continue with the usual
practice of purchasing drugs from vendors trying to
uphold the real context of home management of malaria
(HMM). This however could be a draw back as the quality
of drugs brought from the vendors may be sub-optimal.
One possible effect of sub-standard drug is that many of
the prompt and seemingly correct treatments may not be
beneficial to the health of the child and could also encour-
age development of resistance to drug by parasites. How-
ever, this was refuted by the cure rate observed in the
follow-up study nested into this study. The overall D14
cure rate was 76.8% and by site, it was 91.3% in the inter-
vention arm and 63.3% in the control site. The significant
difference in cure rate in the two arms of the study dem-
onstrates the positive effect of the intervention and the
importance of compliance in achieving positive outcome
with chloroquine treatment. It also support the use of
over-the -counter bought chloroquine for malaria treat-
ment. However, compliance by caregivers must be
emphasized and ensured. Inclusion of drug stability test,
measurement of drug plasma levels [15] and measure-
ment of treatment outcome (such as cure rate) using drugs
bought from vendors as done in this study will provide
strong evidence for either continuing the use of drug ven-
dors to distribute chloroquine for HMM or discouraging
it. Other ways to encourage sale of quality drugs is
through training and monitoring of the activities of the
drug vendors.
Conclusion
This study confirms earlier reports that majority of treat-
ment for malaria take place in the home with drugs
bought from drug vendors. It also provided evidence for
the effectiveness of community-based approach to
malaria treatment. "Mother trainers" were found to be
effective in the delivery of health education messages and
remarkable improvement in adherence to drug treatment
of children suffering from malaria was achieved. The use
of treatment guideline to complement training stands to
further improve knowledge of mothers and adherence to
malaria treatment with chloroquine at home. It is worth-
while to evaluate this mode of intervention (health educa-
tion plus treatment guideline developed using
participatory approach) in the use of artemisinin based
combination drugs such as artemether-lumefantrine
which is now the drug of choice in the treatment of acute
uncomplicated malaria in Nigeria.
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